AHSP (1999) Best practices for health-system pharmacy: positions and practice standards of ASHP 1999-2000. American Society for Health-System Pharmacists, Bethesda, MD. ISBN: 1-979907-99-2.

Avorn J, Soumerai SB, Taylor W, et al. (1988) Reduction of incorrect antibiotic dosing through a structured educational order form. Archives of Internal Medicine 148: 1720-1724.

Aylward P (1996) Acute myocardial infarction: early treatment. Australian Prescriber 19: 52-54.

Bates D, Spell M, Cullen D, et al. (1997) The costs of adverse drug events in hospitalized patients. JAMA 277(4): 307-311.

Bero L, Cho MK (1994) Instruments for assessing the quality of drug studies published in the medical literature. JAMA 272(2): 101-104.

Biomed (2000) Appraisal of guidelines for research and evaluation in Europe (AGREE) instrument, 2nd draft, BIOMED project PL96-3669; website: http://www.agreecollaboration.org

Crawford S, Santell JP (1994) ASHP national survey of pharmaceutical services in federal hospitals - 1993. American Journal of Hospital Pharmacy 51: 2377-2393.

Essential Drugs Programme South Africa (1998) Standard treatment guidelines and essential drug lists for (1) primary health care level, (2) hospital level adults, (3) hospital level paediatrics. National Department of Health, Pretoria; website http://www.doh.gov.za; http://pharmis.pwv.gov.za/publications1.htm

Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M (1990) Changing surgical antimicrobial prohylaxis practices through education targeted at senior department leaders. Infection Control in Hospital Epidemiology 11: 578-583.

Fibrinolytic Therapy Trialists Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343(742): 311-322.

Fowkes FGR, Fulton PM (1991) Critical appraisal of published research: introductory guidelines. BMJ 1991; 302: 1136-1140.

Frick MH, Elo O, Haapa K, et al. (1987) Helsinki heart study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia. New England Journal of Medicine 317: 1237-1245.

Grimshaw JG, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342: 1317-1322.

Hadiyono JE, Suryawati S, Sulanto S, Sunartono D, Santoso B (1996) Interactional group discussion: results of a controlled trial using a behavioural intervention to reduce the use of injections in public health facilities, Social Science and Medicine 42(8): 1177-1183.

Hogerzeil H (1995) Promoting rational drug use: an international perspective. British Journal of Clinical Pharmacology 39: 1-6.

Holloway KA, Gautam BR, Reeves BC (2001a) The effects of different kinds of user fee on prescribing quality in rural Nepal. Journal of Clinical Epidemiology 54: 1065-1071.

Holloway KA, Gautam BR, Reeves BC (2001b) The effects of different kinds of user fee on prescribing costs in rural Nepal. Health Policy and Planning 16(4): 421-427.

Ilet KF, Johnson S, Greenhill G, et al. (2000) Modification of general practitioner prescribing of antibiotics by use of a therapeutics advisor (academic detailer). British Journal of Clinical Pharmacology 49(2): 168-173.

Kafuko J, Zirabumuzale C, Bagenda D (1994) Rational drug use in rural health units in Uganda: effect of national standard treatment guidelines on rational drug use. UNICEF, Washington, DC.

Laing R, Hogerzeil HV, Ross-Degnan D (2001) Ten recommendations to improve the use of medicines in developing countries. Health Policy and Planning 16(1): 13-20.

Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1206.

MSH (1996) Manual for the development and maintenance of hospital drug formularies. Russia Rational Pharmaceutical Management Project. Management Sciences for Health, Arlington, VA; website: http://www.msh.org

MSH (1997) Managing drug supply, 2nd edn. Management Sciences for Health, Kumarian Press, West Hartford, CT. ISBN: 1-56549-047-9.

MSH (annual) International drug price indicator guide. Published by Management Sciences for Health in collaboration with WHO; websites: http://www.msh.org/publications; http://erc.msh.org; http://www.who.int/medicines/organization/par/ipc/drugpriceinfo.shtml

Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (1995) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC. ISBN: 1-55581-086-1.

O’Brien MA, Oxman AD, Davis DA, et al. (2000) Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Systematic Review (2): CD000409.

Phillips D, Christenfeld N (1998) Increase in U.S. medication error deaths between 1983 and 1993. Lancet 351(9103): 643-644.

SIGN (1999) An introduction to SIGN methodology for the development of evidence-based clinical guidelines. SIGN Publication no.39, Scottish Intercollegiate Guidelines Network, Edinburgh; website: http://www.sign.ac.uk

Therapeutic Guidelines Ltd (2000) Therapeutic guidelines: antibiotics, 11th edn. Therapeutic Guidelines Ltd, North Melbourne, Victoria, Australia. ISSN: 1329-5039; website: http://www.tg.com.au

Weekes LM, Brooks C (1996) Drugs and therapeutics committees in Australia: expected and actual performance. British Journal of Clinical Pharmacology 42(5): 551-557.

Wenzel R, Edmond M, Pittet D, et al. (1998) A guide to infection control in the hospital. An official publication of the International Society for Infectious Diseases. B.C. Decker Inc., Hamilton, Ontario, Canada; website: http://www.bcdecker.com

WHO (1979) International pharmacopoeia, 3rd edn, vol. 1: General methods of analysis. World Health Organization, Geneva. ISBN: 92-4-154151-2.

WHO (1981) International pharmacopoeia, 3rd edn, vol. 2: Quality specifications. World Health Organization, Geneva. ISBN: 92-4-154150-4.

WHO (1985) Rational use of drugs: report of the conference of experts, Nairobi, Kenya, 25-29 November. World Health Organization, Geneva. ISBN: 92-4-156105-X.

WHO (1986) Basic tests for pharmaceutical substances. World Health Organization, Geneva. ISBN: 92-4-154204-7.

WHO (1988a) Ethical criteria for medicinal drug promotion. World Health Organization, Geneva.

WHO (1988b) International pharmacopoeia, 3rd edn, vol. 3: Quality specifications. World Health Organization, Geneva. ISBN: 92-4-154215-2.

WHO (1991) Basic tests for pharmaceutical dosage forms. World Health Organization, Geneva. ISBN: 92-4-154418-X.

WHO (1993) How to investigate drug use in health facilities: selected drug use indicators. World Health Organization, Geneva. WHO/DAP/93.1.

WHO (1994a) Guide to good prescribing: a practical manual. World Health Organization, Geneva. WHO/DAP/ 94.11.

WHO (1994b) Injection use and practices in Uganda. World Health Organization, Geneva. WHO/DAP/94.18.

WHO (1994c) International pharmacopoeia, 3rd edn, vol. 4: Tests, methods and general requirements: quality specifications for pharmaceutical substances, excipients and dosage forms. World Health Organization, Geneva. ISBN: 92-4-154462-7.

WHO (1998) Basic tests for drugs: pharmaceutical substances, medicinal plant materials and dosage forms. World Health Organization, Geneva. ISBN: 92-4-154513-5.

WHO (1999a) Quality assurance of pharmaceuticals: a compendium of guidelines and related materials, vol. 2: Good manufacturing practices and inspection. World Health Organization, Geneva. ISBN: 92-4-154526.

WHO (1999b) Medical products and the Internet: a guide to finding reliable information. World Health Organization, Geneva. WHP/EDM/QSM/99.4.

WHO (2000) The use of essential drugs. Report of the WHO Expert Committee. Technical Report Series No.895. World Health Organization, Geneva. ISBN: 92-4-120895-3.

WHO (2001) Protocol for the assessment of national communicable disease surveillance and response systems: guidelines for assessment teams. World Health Organization, Geneva. WHO/CDS/CSR/ISR/2001.2.

WHO (2002a) The selection and use of essential medicines (includes the WHO Model List of Essential Medicines) Report of the WHO Expert Committee. Technical Report Series No. 914, World Health Organization, Geneva; website: http://www.who.int/medicines/organization/par/edl/expertcomm.shtml

WHO (2002b) WHO model formulary. World Health Organization, Geneva. ISBN:92-4-154559-3; website: http://www.who.int/medicines/organization/par/formulary.shtml WHO (2002c) Promoting rational use of medicines: core components. Policy Perspectives Paper on Medicines No. 5, WHO/EDM. World Health Organization, Geneva.

WHO (2003) International pharmacopoeia, 3rd edn, vol. 5: Tests and general requirements for dosage forms: quality specifications for pharmaceutical substances and tablets. World Health Organization, Geneva. ISBN: 92-4-154536-4.

WHO/UNICEF/UNFPA/WB (1999) Operational principles for good pharmaceutical procurement. World Health Organization, Geneva. WHO/EDM/PAR/99.5.

Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-530.

Zimbabwe DTC Manual (1999) Establishing an effective drug & therapeutics committee: a practical manual developed in Zimbabwe. National Drug and Therapeutics Policy Advisory Committee, October 1999.